April 09, 2019
Rose
Dr. Russell Portenoy spent decades of his career touting the benefits of powerful prescription painkillers. Now, Portenoy will testify that companies “overstated the benefits of chronic-opioid therapy" and “understated the risks of opioids, particularly the risk of abuse, addiction and overdose," according to a federal-court filing. In other news on the drug crisis: foster care and the epidemic, Purdue Pharma's connection to Tufts Medical School, addiction treatment, and more.
from Kaiser Health News http://bit.ly/2UHor9J
April 09, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Viewpoints: Physicians Rightfully Worry About Multiple Longterm Effects Of Epidemic; Decisions On Allocating Care Get More Difficult- Longer Looks: Public Housing, Small Pox Experts, Climate Change In The Time Of Coronavirus, And More
- The Nation’s 5,000 Outpatient Surgery Centers Could Help With The COVID-19 Overflow
- Different Takes: Lessons From Wuhan On How To End The Pandemic; Postponing Abortions Is Medically Negligent
- ‘Red Dawn Breaking Bad’: Officials Warned About Safety Gear Shortfall Early On, Emails Show
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment